Agreements formalize research partnership combining InterCure’s global pharmaceutical platform with Cannasoul’s world-class analytics and scientific innovation Collaboration comes amidst reports that ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

People with cancer who received diabetes care from clinical pharmacists achieved significantly better blood sugar control, ...

In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli ...

State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules.

Rising tensions between the NHS and pharmaceutical companies are testing how much the health service can afford to pay for new branded medicines.

Nigel Langley of gChem discusses the company’s DMSO, proactive pharma strategies, and more in part 1 of a 2-part interview ...

The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing ...

Scotland’s life sciences sector is at a crossroads, facing significant challenges but also unprecedented opportunities.

Proteins play a key role not only in the body, but also in medicine: they either serve as active ingredients, such as enzymes ...

BlackDoctor.org, a health platform that reaches 20 million people, launched a new initiative, Generational Health, that aims ...